PTPN18 (Protein Tyrosine Phosphatase Non-Receptor Type 18) is a suppressor of breast cancer metastasis, thereby providing a potential effective antimetastatic therapeutic strategy. This evidence concerns the gene PTPN18 and breast carcinoma.